InvestorsHub Logo
Followers 0
Posts 6
Boards Moderated 0
Alias Born 03/03/2009

Re: ScovilleUnits post# 4

Monday, 04/27/2009 10:49:41 AM

Monday, April 27, 2009 10:49:41 AM

Post# of 44
Endocare manufactures a machine that is used to freeze prostate, kidney, lung, and liver tumors. These procedures have become more widely used now since most people want minimally invasive therapy as opposed to open surgery. The long term data on the efficacy of cryoablation is now available to physicians so they are choosing to use cryo more as a first line therapy. Cryo is also the only viable option for men with prostate cancer who have failed radiation seed therapy so usage after radiation failure will become more widespread also. Procedure volume is picking up nationwide (I still have access to the schedule lol)which should give a significant increase in Endocares income. Galil was their only major competitor so after the merger they will be the only company providing cryoablation equipment. Healthtronics (HTRN) is the mobile provider for Endocare. They provide the hospital with the equipment and the technician to do the procedure. This way the hospital just pays per case and has no capital equipment outlay. This is an excellent business model since Endocare sells everything to HTRN. All they have to do is market the procedure to physicians and they dont have to convince hospital to buy an expensive peice of equipment. The new company should go with HTRN to provide services so you may want to look at them also. All I can say is I have tripled my investment thus far. And all of this is just IMHO

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.